ZHIHU-W (02390) repurchased approximately 99,000 shares at a cost of about $114,900 on February 5th.
Zhihu-W (02390) announced on February 5, 2026 that it will spend approximately $114,900 to repurchase 99,000 shares.
ZHIHU-W (02390) announced a repurchase of approximately 99,000 shares at a cost of approximately $114,900 on February 5, 2026.
Related Articles
Huaqin Technology (603296.SH): Hong Kong Stock Exchange considers company's issuance of H shares.
CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit attributable to shareholders in 2025 is approximately 3.422 billion yuan, an increase of 1.6% year-on-year.
CareRay Digital Medical Technology (688607.SH) plans to increase capital of 70 million yuan to cultivate growth points for Pulse Intelligence.
Huaqin Technology (603296.SH): Hong Kong Stock Exchange considers company's issuance of H shares.
CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit attributable to shareholders in 2025 is approximately 3.422 billion yuan, an increase of 1.6% year-on-year.
CareRay Digital Medical Technology (688607.SH) plans to increase capital of 70 million yuan to cultivate growth points for Pulse Intelligence.
